Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Astaxanthin
(
AST
), a natural marine carotenoid, possess a wide variety of biological functions. In particular, as a strong antioxidant,
AST
effectively scavenges oxygen free radicals and reduces oxidative stress. In addition, recent
in vitro
studies have suggested that
AST
attenuates glutamate-induced apoptosis and cytotoxicity. The glutamate/aspartate transporter (GLAST) deficient (GLAST
-/-
) mouse is a mouse model of normal tension glaucoma (NTG) caused by both the glutamate neurotoxicity and oxidative stress in the retina. In the present study, we investigated the effects of
AST
on the ganglion cell complex, indicator of glaucomatous structural damage, using spectral domain-optical coherence tomography. As a result,
AST
significantly attenuated the
thinning
of ganglion cell complex in GLAST
-/-
mice in comparison to an
AST
-free control group. Our results suggest the possibility that
AST
has protective effects against glutamate neurotoxicity and oxidative stress in the retina. At present, the only treatment for NTG that is available in the clinical setting is to reduce the IOP as much as possible. Thus, our results suggest that
AST
supplementation may be effective for some types of NTG in which glutamate neurotoxicity and oxidative stress are involved.
...
PMID:The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography. 3263 59